Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Carbohydrate Metabolism

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Oral Hypoglycemic Agents: Biguanides and Glitazones

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Using human genetic variation to estimate the effect of lipoprotein(a) lowering on pregnancy outcomes.

medRxiv : the preprint server for health sciences·2026

Same author

A Phase 2 (2a) Randomized Trial of Iscalimab in Adolescents and Young Adults with New-Onset Type 1 Diabetes.

Diabetes technology & therapeutics·2025

Same author

Barriers to translating continuous monitoring technologies for preventative medicine.

Nature biomedical engineering·2025

Same author

Complete loss of SLC30A8 in humans improves glucose metabolism and beta cell function.

Diabetologia·2025

Same author

Immunogenicity assessment strategy for a chemically modified therapeutic protein in clinical development.

Frontiers in immunology·2024

Same author

Identification and characterization of human GDF15 knockouts.

Nature metabolism·2024

Search research articles

Related Experiment Video

Updated: May 14, 2026

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Published on: October 18, 2024

Metabolic surgery for type 2 diabetes: efficacy and risks.

Florencia Halperin¹, Allison B Goldfine

¹Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Current Opinion in Endocrinology, Diabetes, and Obesity

|February 14, 2013

Summary

Bariatric surgery effectively manages type 2 diabetes mellitus (T2DM) and obesity. Studies show surgical interventions improve glycemic control more than medical management, offering insights into metabolic changes.

More Related Videos

Sleeve Gastrectomy in Mice using Surgical Clips

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

A Murine Model of Vertical Sleeve Gastrectomy

A Murine Model of Vertical Sleeve Gastrectomy

Published on: December 18, 2017

Related Experiment Videos

Last Updated: May 14, 2026

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Published on: October 18, 2024

Sleeve Gastrectomy in Mice using Surgical Clips

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

A Murine Model of Vertical Sleeve Gastrectomy

A Murine Model of Vertical Sleeve Gastrectomy

Published on: December 18, 2017

Area of Science:

Metabolic surgery
Diabetes mellitus research
Obesity treatment

Background:

Bariatric surgery is a recognized effective treatment for obesity.
It offers significant benefits for glycemic management in patients with type 2 diabetes mellitus (T2DM).
The role of bariatric surgery in diabetes prevention is increasingly acknowledged.

Purpose of the Study:

To review the efficacy of metabolic surgery for T2DM treatment.
To explore the underlying mechanisms of metabolic surgery in managing T2DM.

Main Methods:

Review of recent small randomized controlled studies (1-2 years follow-up).
Analysis of physiological studies using advanced metabolic techniques.
Evaluation of insulin secretion, action, and entero-endocrine changes pre- and post-surgery.

Main Results:

Level 1 data from randomized studies demonstrate surgical procedures' superior effect on glycemic control compared to medical management.
Physiological studies elucidate mechanisms behind glycemic changes post-bariatric surgery, including insulin dynamics and entero-endocrine alterations.

Conclusions:

Understanding bariatric surgery's metabolic effects is crucial for managing the obesity and T2DM epidemics.
Insights gained may lead to developing less invasive, equally effective therapeutic strategies for weight loss and metabolic control.